BioNTech : AGM Voting Results

BioNTech SE, Mainz, Germany

Annual General Meeting in Munich, Germany, 22 June 2021

Voting results - Overview - Only the German version is binding

Agenda Item 2			Approval of the actions of the Management Board - accepted
139,683,231			Number of shares for which valid votes were cast (= 56.71 % of the registered share capital)
139,665,613	Yes votes	99.99 % of the valid votes cast
	17,618	No votes	0.01 % of the valid votes cast
Agenda Item 3			Approval of the actions of the Supervisory Board - accepted
174,869,015			Number of shares for which valid votes were cast (= 71.00 % of the registered share capital)
174,546,675	Yes votes	99.82 % of the valid votes cast
	322,340	No votes	0.18 % of the valid votes cast
Agenda Item 4			Appointment of the auditor for the 2021 financial year - accepted
179,468,511			Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
179,212,710	Yes votes	99.86 % of the valid votes cast
	255,801	No votes	0.14 % of the valid votes cast
Agenda Item 5			Resolution on the revocation of the existing authorized capital and the creation of a new
			authorized capital (Authorized Capital 2021) against contributions in cash and/or in kind with the
			possibility of excluding subscription rights and corresponding amendments to the Articles of
			Association - accepted
179,458,549	Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
172,249,826	Yes votes	95.98 % of the valid votes cast
7,208,723	No votes	4.02 % of the valid votes cast
Agenda Item 6			Amendment of the authorization to issue stock options - accepted
179,451,731			Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
178,976,669	Yes votes	99.74 % of the valid votes cast
	475,062	No votes	0.26 % of the valid votes cast
Agenda Item 7			Resolution on the partial revocation and amendment of the current authorization to issue stock
			options (Stock Option Program 2017/2019) and on the partial revocation of Conditional Capital
			ESOP 2017/2019 / Resolution on the authorization to issue stock options (Stock Option Program
			2021) and on the implementation of a new Conditional Capital 2021 and corresponding
			amendments to the Articles of Association - accepted
179,449,615	Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
178,569,618	Yes votes	99.51 % of the valid votes cast
	879,997	No votes	0.49 % of the valid votes cast
Agenda Item 8			Amendment to the existing authorization to acquire treasury shares and their use, also excluding
			subscription rights - accepted
179,420,084			Number of shares for which valid votes were cast (= 72.84 % of the registered share capital)
178,821,434	Yes votes	99.67 % of the valid votes cast
	598,650	No votes	0.33 % of the valid votes cast
Agenda Item 9			Extending the authorization to acquire treasury shares and to use them, also excluding
			subscription rights - accepted
179,421,159			Number of shares for which valid votes were cast (= 72.84 % of the registered share capital)
177,245,311	Yes votes	98.79 % of the valid votes cast
2,175,848	No votes	1.21 % of the valid votes cast
Agenda Item 10			Resolution on the approval of the system for the compensation of the members of the
			Management Board - accepted
179,453,511			Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
178,335,590	Yes votes	99.38 % of the valid votes cast
1,117,921	No votes	0.62 % of the valid votes cast

BioNTech SE, Mainz, Germany

Annual General Meeting in Munich, Germany, 22 June 2021

Voting results - Overview - Only the German version is binding

Agenda Item 11		Resolution on the compensation and on the compensation system for the members of the
		Supervisory Board and an amendment of Sec. 9 para. 6 of the Articles of Association - accepted
177,349,170			Number of shares for which valid votes were cast (= 72.00 % of the registered share capital)
177,145,624	Yes votes	99.89 % of the valid votes cast
203,546	No votes	0.11 % of the valid votes cast
Agenda Item 12		Resolution on the revocation of the resolution of the Company's Annual General Meeting of June
		26, 2020 (agenda item 8 letter d)) on the consent to the conclusion of the domination and profit
		and loss transfer agreement between the Company as controlling company and JPT Peptide
		Technologies GmbH as dependent company - accepted
179,452,623	Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
179,428,491	Yes votes	99.99 % of the valid votes cast
24,132	No votes	0.01 % of the valid votes cast
Agenda Item 13 a)		Approval of the conclusion of the domination and profit and loss transfer agreement between the
		Company as controlling company and JPT Peptide Technologies GmbH as dependent company
		- accepted
179,452,355			Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
179,428,811	Yes votes	99.99 % of the valid votes cast
23,544	No votes	0.01 % of the valid votes cast
Agenda Item 13 b)		Approval of the conclusion of the domination and profit and loss transfer agreement between the
		Company as controlling company with BioNTech Manufacturing Marburg GmbH as dependent
		company - accepted
179,455,727	Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
179,435,690	Yes votes	99.99 % of the valid votes cast
20,037	No votes	0.01 % of the valid votes cast
Agenda Item 13 c)		Approval of the conclusion of the domination and profit and loss transfer agreement between the
		Company as controlling company and reSano GmbH as dependent company - accepted
179,453,445			Number of shares for which valid votes were cast (= 72.86 % of the registered share capital)
179,432,707	Yes votes	99.99 % of the valid votes cast
20,738	No votes	0.01 % of the valid votes cast